Dr. Michael LaValley, professor of biostatistics at Boston University School of Public Health, has won the Distinguished Scholar Award from the Association of Rheumatology Professionals (ARP), a division of the American College of Rheumatology. He will receive the award during the organization’s Annual Meeting November 8-13 in Atlanta, GA.
The Distinguished Scholar Award is presented to an ARP member who demonstrates “exceptional achievements in scholarly activities” related to arthritis and the rheumatic diseases. In collaboration with research teams in the Clinical Epidemiology Research and Training Unit at Boston University School of Medicine and Boston Medical Center over the past 25 years, Dr. LaValley has assessed osteoarthritis progress for clinical trials and longitudinal studies and performed meta-analyses to evaluate treatments for rheumatic diseases.
“As a society, we’re getting older, and knee replacements and hip replacements have become a very common procedure over the past 10 or 20 years,” says Dr. LaValley, adding that pre and post-surgery care can add to the overall cost of treatment. “Many rheumatic conditions, such as lupus and rheumatoid arthritis, require monoclonal antibody treatments which are very expensive, and people are usually on these medications for life.”Friday Letter Submission, Publish on October 04